StockData
Whitehawk Therapeutics, Inc. logo

Whitehawk Therapeutics, Inc. (WHWK) stock

WHWKNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 8/30
$3.08+0.07 (+2.33%)

Close on Nov 17, 2026Market cap $175.59MP/E –Yield –

Whitehawk Therapeutics EV/EBITDA

EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.

Whitehawk Therapeutics's EV/EBITDA was 4.3× on Jul 30, 2021.

EV/EBITDA at the end of each year

PeriodPeriod endValueChange (pts)
2021Jul 30, 20214.3×–

More Whitehawk Therapeutics figures

See a number that looks wrong?